US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 13.100
  • +0.090+0.69%
Close Dec 20 16:00 ET
  • 13.100
  • 0.0000.00%
Post 20:01 ET
41.68BMarket Cap22.66P/E (TTM)

About Takeda Pharmaceutical Company

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Company Profile

SymbolTAK
Company NameTakeda Pharmaceutical
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketNYSE
Employees49281
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111
Websitehttp://www.takeda.com

Company Executives

  • Name
  • Position
  • Salary
  • Christophe Weber
  • Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
  • 1.70B
  • Akiko Amakawa
  • Corporate Strategy Officer and Chief Executive Officer Chief of Staff
  • --
  • Lauren Duprey
  • Chief Human Resources Officer
  • --
  • Milano Furuta
  • Director and Chief Financial Officer
  • --
  • Mwana Lugogo
  • Chief Ethics and Compliance Officer
  • --
  • Gabriele Ricci
  • Chief Data and Technology Officer
  • --
  • Takako Ohyabu
  • Chief Global Corporate Affairs and Sustainability Officer
  • --
  • Elaine Shannon
  • Global Quality Officer
  • --
  • Dr. Thomas Wozniewski, PhD
  • Global Manufacturing and Supply Officer
  • --
  • Marcello Agosti
  • Global Business Development Officer
  • --
  • Giles Platford
  • President, Plasma-Derived Therapies Business Unit
  • --
  • Ramona Sequeira
  • President, Global Portfolio Division
  • --
  • Julie Kim
  • President, U.S. Business Unit and U.S. Country Head
  • --
  • Teresa Marie Bitetti
  • President, Global Oncology Business Unit
  • --
  • Masami Iijima
  • Chairman of the Board
  • 43.00M
  • Asuka Miyabashira
  • President, Japan Pharma Business Unit
  • --
  • Andrew S. Plump, M.D.
  • Director and President, Research and Development
  • 12.00M
  • Koji Hatsukawa
  • Independent Director
  • 43.00M
  • Jean-Luc Butel
  • Independent Director
  • 38.00M
  • Ian T. Clark
  • Independent Director
  • 44.00M
  • Miki Tsusaka
  • Independent Director
  • 32.00M
  • Emiko Higashi
  • Independent Director
  • 49.00M
  • Dr. Steven Gillis, Pd.D
  • Independent Director
  • 44.00M
  • Michel Orsinger
  • Independent Director
  • 46.00M
  • Kimberly A. Reed
  • Independent Director
  • 41.00M
  • Yoshiaki Fujimori
  • Independent Director
  • 40.00M
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 39.00M
  • Yoshihiro Nakagawa
  • Global General Counsel
  • --
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Ermenegildo Zegna NV
ZGN
+6.16%
DexCom
DXCM
+5.57%
New Fortress Energy
NFE
+5.37%
Workday
WDAY
+2.33%
eBay
EBAY
+1.66%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday+0.78%